Literature DB >> 23701810

Cognitive function in older patients with postherpetic neuralgia.

Gisèle Pickering1, Bruno Pereira, Florentin Clère, Marc Sorel, Geraldine de Montgazon, Malou Navez, Pascale Picard, Delphine Roux, Véronique Morel, Rachida Salimani, Mireille Adda, Valérie Legout, Claude Dubray.   

Abstract

BACKGROUND AND AIMS: Neuropathic pain has been shown to be accompanied by cognitive impairment, but the specific impact of postherpetic neuropathic pain on cognitive processes has not been explored. This study aims to evaluate the impact of pain on several domains of cognition in older patients with postherpetic neuralgia (PHN).
METHODS: This cross-sectional study (clinicaltrial.gov NCT 00989040) included 84 individuals after signature of informed consent. PARTICIPANTS: 42 patients with PHN and 42 healthy volunteers. Of the 42 PHN patients, 21 received systemic treatment (antidepressants, anticonvulsants, opiates) and 21 had topical treatment with the 5% lidocaine medicated plaster. All participants performed a panel of four cognitive tests: reaction time, semantic memory, decision-making, and visual memory (Cantab, Cambridge).
RESULTS: Forty men and 44 women with a mean age of 72 ± 8 years participated. Each PHN patient was matched by age and gender with a healthy volunteer. Vigilance, decision-making, and semantic memory were significantly impaired (P < 0.05) in patients on systemic treatment, especially with antidepressants, while no significant changes were noted between the lidocaine plaster group and their matched controls of healthy volunteers.
CONCLUSION: This study shows the deleterious effect of systemic PHN treatment on several domains of cognition. Cognitive impairment associated with pain and antidepressants may be reversed by topical pain management. Topical treatment with 5% lidocaine medicated plaster is a valuable alternative for pain alleviation and maintains cognitive integrity in this vulnerable population.
© 2013 World Institute of Pain.

Entities:  

Keywords:  analgesics; cognitive impairment; neuropathic pain; postherpetic neuralgia; topical lidocaine

Mesh:

Substances:

Year:  2013        PMID: 23701810     DOI: 10.1111/papr.12079

Source DB:  PubMed          Journal:  Pain Pract        ISSN: 1530-7085            Impact factor:   3.183


  20 in total

Review 1.  Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective.

Authors:  Robert W Johnson; Marie-José Alvarez-Pasquin; Marc Bijl; Elisabetta Franco; Jacques Gaillat; João G Clara; Marc Labetoulle; Jean-Pierre Michel; Luigi Naldi; Luis S Sanmarti; Thomas Weinke
Journal:  Ther Adv Vaccines       Date:  2015-07

Review 2.  Topical Treatment of Localized Neuropathic Pain in the Elderly.

Authors:  Gisèle Pickering; Camille Lucchini
Journal:  Drugs Aging       Date:  2020-02       Impact factor: 3.923

Review 3.  Topical analgesics for neuropathic pain in the elderly: current and future prospects.

Authors:  Jana Sawynok
Journal:  Drugs Aging       Date:  2014-12       Impact factor: 3.923

4.  Fibromyalgia, milnacipran and experimental pain modulation: study protocol for a double blind randomized controlled trial.

Authors:  Nicolas Macian; Bruno Pereira; Coralie Shinjo; Claude Dubray; Gisèle Pickering
Journal:  Trials       Date:  2015-04-03       Impact factor: 2.279

5.  5% Lidocaine Medicated Plaster for the Treatment of Postherpetic Neuralgia: A Review of the Clinical Safety and Tolerability.

Authors:  Marie Louise Navez; Christopher Monella; Irmgard Bösl; Daniela Sommer; Claire Delorme
Journal:  Pain Ther       Date:  2015-04-21

6.  Memantine before Mastectomy Prevents Post-Surgery Pain: A Randomized, Blinded Clinical Trial in Surgical Patients.

Authors:  Véronique Morel; Dominique Joly; Christine Villatte; Claude Dubray; Xavier Durando; Laurence Daulhac; Catherine Coudert; Delphine Roux; Bruno Pereira; Gisèle Pickering
Journal:  PLoS One       Date:  2016-04-06       Impact factor: 3.240

Review 7.  Antiepileptics for post-herpetic neuralgia in the elderly: current and future prospects.

Authors:  Gisèle Pickering
Journal:  Drugs Aging       Date:  2014-09       Impact factor: 4.271

Review 8.  Practical considerations in the pharmacological treatment of postherpetic neuralgia for the primary care provider.

Authors:  Jamie S Massengill; John L Kittredge
Journal:  J Pain Res       Date:  2014-03-10       Impact factor: 3.133

9.  Reduction of painful area as new possible therapeutic target in post-herpetic neuropathic pain treated with 5% lidocaine medicated plaster: a case series.

Authors:  Roberto Casale; Maria Di Matteo; Cristina E Minella; Guido Fanelli; Massimo Allegri
Journal:  J Pain Res       Date:  2014-06-23       Impact factor: 3.133

Review 10.  Psychological Considerations in the Assessment and Treatment of Pain in Neurorehabilitation and Psychological Factors Predictive of Therapeutic Response: Evidence and Recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation.

Authors:  Gianluca Castelnuovo; Emanuele M Giusti; Gian Mauro Manzoni; Donatella Saviola; Arianna Gatti; Samantha Gabrielli; Marco Lacerenza; Giada Pietrabissa; Roberto Cattivelli; Chiara A M Spatola; Stefania Corti; Margherita Novelli; Valentina Villa; Andrea Cottini; Carlo Lai; Francesco Pagnini; Lorys Castelli; Mario Tavola; Riccardo Torta; Marco Arreghini; Loredana Zanini; Amelia Brunani; Paolo Capodaglio; Guido E D'Aniello; Federica Scarpina; Andrea Brioschi; Lorenzo Priano; Alessandro Mauro; Giuseppe Riva; Claudia Repetto; Camillo Regalia; Enrico Molinari; Paolo Notaro; Stefano Paolucci; Giorgio Sandrini; Susan G Simpson; Brenda Wiederhold; Stefano Tamburin
Journal:  Front Psychol       Date:  2016-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.